Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01808183 · ClinicalTrials.gov registry record

Pediatric Supracondylar Humerus Fracture NIRS Study

A clinical trial of Supracondylar Humerus Fracture, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
90
Enrollment target
1
Study location

NCT01808183: Completed study of Supracondylar Humerus Fracture, sponsored by Wake Forest University Health Sciences.

NCT01808183 is a study of Supracondylar Humerus Fracture that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 90 participants, below the 158-participant average among 3 other Supracondylar Humerus Fracture trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01808183, a study of Supracondylar Humerus Fracture, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to use a device to compare the blood flow in the patient's injured arm to the patient's uninjured arm. This will help us determine 'normal' readings for this device for a child's forearm and may in the future help us detect children that have injured the blood vessels that go to the forearm when they have an elbow fracture. The patient will be one of approximately 100 people involved in this research project at Carolinas Medical Center, and the patient's participation will last until the patient is discharged from the hospital. It is hypothesized that if the blood vessel is uninjured, the readings on the NIRS device on the injured arm will be equal to the uninjured arm. It is also hypothesized that if the blood vessel of the injured arm is injured, the readings on the NIRS device will be different than on the uninjured arm.

Interventions

  • DEVICE Near Infrared Spectroscopy Pads

Study Locations (1)

North Carolina

  • Carolinas HealthCare System: Levine Children's Hospital - Charlotte

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2012-02
Est. Completion 2017-02
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT01808183 record still lists

NCT01808183 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 158-participant average among 3 other Supracondylar Humerus Fracture trials with a reported enrollment target (43% lower).

The record links to 1 condition, with Supracondylar Humerus Fracture appearing as the primary indexed condition, and to 1 intervention - of which Near Infrared Spectroscopy Pads is the first listed.

NCT01808183 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01808183 about?

NCT01808183 is a clinical study titled "Pediatric Supracondylar Humerus Fracture NIRS Study". The purpose of this study is to use a device to compare the blood flow in the patient's injured arm to the patient's uninjured arm. This will help us determine 'normal' readings for this device for a child's forearm and may in the future help us detect children that have injured the blood vessels th...

What is the current status of trial NCT01808183?

This trial is currently completed. The enrollment target is 90 participants. The study started on 2012-02. Estimated completion is 2017-02.

What conditions does trial NCT01808183 study?

This clinical trial studies the following conditions: Supracondylar Humerus Fracture.

What interventions are being tested in trial NCT01808183?

The interventions under investigation include: Near Infrared Spectroscopy Pads (DEVICE).

Who is sponsoring clinical trial NCT01808183?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01808183 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Supracondylar Humerus Fracture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01808183, the US trial registry maintained by the National Library of Medicine. NCT01808183 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.